Data for: “Real-World” Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States

Published: 29 Jul 2018 | Version 1 | DOI: 10.17632/ny239y2p9m.1
Contributor(s):

This dataset is under embargo and will be publicly available (168 days) on 02 June 2019 at 12:00am UTC

Download calendar event

What does under embargo mean?

This data is associated with the following publication:

Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States

Published in: Ophthalmology Retina

Latest version

  • Version 1

    Under embargo

    Embargo Date: 2019-06-02 (168 days)

    Published: 2018-07-29

    DOI: 10.17632/ny239y2p9m.1

    Cite this dataset

    Ciulla, Thomas; Bracha, Peter; Pollack, John; Williams, David (2018), “Data for: “Real-World” Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States”, Mendeley Data, v1 http://dx.doi.org/10.17632/ny239y2p9m.1

Categories

Diabetes, Retrospective Study, Retinal Disease

Mendeley Library

Organise your research assets using Mendeley Library. Add to Mendeley Library

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?

This dataset is licensed under a Creative Commons Attribution 4.0 International licence. What does this mean? You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report